DXS International Valuation

Is DXSP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DXSP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate DXSP's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate DXSP's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DXSP?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for DXSP. This is calculated by dividing DXSP's market cap by their current preferred multiple.
What is DXSP's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	n/a

DXSP key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.4x
Enterprise Value/EBITDA	12.7x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does DXSP's PE Ratio compare to its peers?

The above table shows the PE ratio for DXSP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	37.5x
INS Instem	59.8x	n/a	UK£199.6m
PHSC PHSC	11.8x	n/a	UK£2.9m
CODE CodeLab Capital	0.5x	n/a	NOK 22.6m
CRW Craneware	77.9x	24.3%	UK£702.5m
DXSP DXS International	13.1x	n/a	UK£992.3k

Price-To-Earnings vs Peers: DXSP is good value based on its Price-To-Earnings Ratio (13.1x) compared to the peer average (30.1x).

Price to Earnings Ratio vs Industry

How does DXSP's PE Ratio compare vs other companies in the European Healthcare Services Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	27.3%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	27.3%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: DXSP is good value based on its Price-To-Earnings Ratio (13.1x) compared to the European Healthcare Services industry average (19x).

Price to Earnings Ratio vs Fair Ratio

What is DXSP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DXSP PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	13.1x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate DXSP's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.